MCL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In this study, MCL1 was significantly enriched in antiapoptosis pathways, especially in the resistance to exogenous withering upon the death signal, indicating that MCL1 may be closely related to CML HSC resistance and apoptotic escape and may be used as a candidate target for the treatment of CML resistance.